Latest Cancer News

Interim Results of X-396 in ALK positive Non-Small Cell Lung Cancer Appear Promising (08-29-2014)
Preliminary results from a small phase 1 study of X-396, a novel anaplastic lymphoma kinase (ALK) inhibitor showed that X-396 is well tolerated and has antitumor activity in patients with ALK positive... Continue Reading

Risk of Breast Cancer Recurrence Doesn’t Increase with TNF Inhibitor Use (08-28-2014)
According to the results of a recently published study from Swedish investigators treatment with tumor necrosis factor inhibitors (TNF) does not appear to increase the rate of breast cancer recurrence... Continue Reading

Advaxis and Merck Form Collaboration to Evaluate Investigational Combination of Two Novel Immunotherapy Candidates for Advanced Prostate Cancer (08-27-2014)
Advaxis, Inc.a clinical-stage biotechnology company developing cancer immunotherapies, has entered into a clinical trial collaboration agreement with Merck to evaluate the safety and efficacy of ADXS-PSA... Continue Reading

More Cancer News

Locations

La Jolla Location
9850 Genesee Ave
Ste 830
La Jolla, CA 92037
858.552.1410
Fax: 858.552.0929
click here for directions
Encinitas Location
477 N. El Camino Real
Ste D200
Encinitas, CA  92024
760.452.3340
Fax: 760.452.3344
click here for directions
Vista Location
161 Thunder Drive
Ste 106
Vista, CA  92083
760.208.6730
Fax: 760.208.6736
click here for directions
Escondido Location
625 W. Citracado Parkway
Suite 110
Escondido, CA  92025
760.747.8935
Fax: 760.747.7951
click here for directions
4 S Ranch Location
16918 Dove Canyon Road
San Diego, CA 92127
Ste 103
858-649-5100
Fax: 858-649-5099
click here for directions